RESEARCH-USE BIOSIMILAR ANTIBODY
Dapirolizumab
Antibody fragment · IgG1
Dapirolizumab is an antibody targeting CD40L (CD154). Dapirolizumab can be used in research related to systemic lupus erythematosus.
TARGETCD40LG
YAntibody fragment
CATALOGSC-BS-642
CATALOG NUMBERSC-BS-642
MOLECULAR WEIGHTApprox. 145.5 kDa
PRODUCT FORMATAntibody fragment
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Dapirolizumab is an antibody targeting CD40L (CD154). Dapirolizumab can be used in research related to systemic lupus erythematosus.
Dapirolizumab is a recombinant research-use antibody directed against CD40LG.